Ronnie Miller Appointed New Chairman, Rx&D Board of Directors

    MONTREAL, Nov. 14 /CNW Telbec/ - Canada's Research-Based Pharmaceutical
Companies (Rx&D) is pleased to announce the appointment of Ronnie Miller,
President and Chief Executive Officer (CEO) of Hoffmann-La Roche Limited
(Roche Canada) as Chairman of the association's Board of Directors. Mr. Miller
assumed the Board leadership at today's Rx&D Annual General meeting held in
    Mr. Miller is a member of Rx&D's Executive Committee and Board of
Directors. Until becoming Board Chairman, he served on several industry
committees including Public Affairs, Stakeholder Relations and, more recently,
as Chair of the Rx&D Federal Affairs/FPT Relations Standing Committee.
    "It is my privilege to serve as Chair of Rx&D's Board of Directors at a
time in our industry where we are truly at a crossroads", said Mr. Miller.
"Now, more than ever, we must galvanize the voice of the life-sciences sector
to break down the barriers preventing physicians from accessing innovation and
putting patients at the centre of all health-care decisions in this country."
    Mr. Miller has over 28 years of extensive and varied experience in the
pharmaceutical industry. He began his career in the United Kingdom as a sales
representative and held a series of progressive positions including Sales
Management, Product Management, Business Unit Director, and National Sales
    In 1988, Mr. Miller joined Roche as National Sales Manager for Roche
Products Ltd. in the United Kingdom. In 1992, he moved to Roche's head office
in Basel, Switzerland, as the International Product Manager for Neupogen(R).
    From 1993-1996, he worked for Roche in Japan as Marketing Director and
Deputy Divisional Director of the Pharmaceutical Division. In 1996, he moved
back to Roche's global head office in Basel, to lead the global task force for
Xenical(R). Mr. Miller returned to the United Kingdom in 1997 as Divisional
Director of Pharmaceuticals and remained there until April 2000, when he was
appointed to his current position as President and CEO, Roche Canada.

    Canada's Research-Based Pharmaceutical Companies (Rx&D) is an association
of members dedicated to improving the health of all Canadians. As a partner of
the health-care system, our discoveries help eliminate the need for medical
procedures, such as surgery, which have a significant impact on patient
quality of life and health-care budgets. Our community represents over 22,000
men and women working for more than 50 member companies in Canada and is
responsible for generating 100,000 jobs across Canada.

For further information:

For further information: François Lessard, Communications, (613)

Organization Profile

Canada's Research-Based Pharmaceutical Companies (Rx&D)

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890